Subcutaneous bortezomib for treatment of TEMPI syndrome

Sina Jasim; Gibran Mahmud; Bahar Bastani; Mark Fesler

doi:10.1016/j.clml.2014.07.004

Subcutaneous bortezomib for treatment of TEMPI syndrome

Sina Jasim
, Gibran Mahmud
, Bahar Bastani
, Mark Fesler

Research output: Contribution to journal › Article › peer-review

Original language	English
Pages (from-to)	e221-e223
Journal	Clinical Lymphoma, Myeloma and Leukemia
Volume	14
Issue number	6
DOIs	https://doi.org/10.1016/j.clml.2014.07.004
State	Published - 2014

Keywords

Monoclonal gammopathy
Neuropathy
Perinephric cysts
Polycythemia
Telangiectasia

Access to Document

10.1016/j.clml.2014.07.004

Cite this

@article{7da6229380b24bed9dcd87154a47728b,

title = "Subcutaneous bortezomib for treatment of TEMPI syndrome",

keywords = "Monoclonal gammopathy, Neuropathy, Perinephric cysts, Polycythemia, Telangiectasia",

author = "Sina Jasim and Gibran Mahmud and Bahar Bastani and Mark Fesler",

year = "2014",

doi = "10.1016/j.clml.2014.07.004",

language = "English",

volume = "14",

pages = "e221--e223",

journal = "Clinical Lymphoma, Myeloma and Leukemia",

issn = "2152-2650",

number = "6",

}

TY - JOUR

T1 - Subcutaneous bortezomib for treatment of TEMPI syndrome

AU - Jasim, Sina

AU - Mahmud, Gibran

AU - Bastani, Bahar

AU - Fesler, Mark

PY - 2014

Y1 - 2014

KW - Monoclonal gammopathy

KW - Neuropathy

KW - Perinephric cysts

KW - Polycythemia

KW - Telangiectasia

UR - https://www.scopus.com/pages/publications/84922552208

U2 - 10.1016/j.clml.2014.07.004

DO - 10.1016/j.clml.2014.07.004

M3 - Article

C2 - 25172534

AN - SCOPUS:84922552208

SN - 2152-2650

VL - 14

SP - e221-e223

JO - Clinical Lymphoma, Myeloma and Leukemia

JF - Clinical Lymphoma, Myeloma and Leukemia

IS - 6

ER -

Subcutaneous bortezomib for treatment of TEMPI syndrome

Keywords

Access to Document

Other files and links

Cite this